• Explore /
  • Poster
  • / Preoperative chemotherapy plus bevacizumab with early salvage therapy based on FDG-PET response in locally advanced gastroesophageal junction and gastric adenocarcinoma.

Preoperative chemotherapy plus bevacizumab with early salvage therapy based on FDG-PET response in locally advanced gastroesophageal junction and gastric adenocarcinoma.

Abstract Poster

Authors

Geoffrey Ku

Geoffrey Yuyat Ku

Memorial Sloan-Kettering Cancer Center, New York, NY

Geoffrey Yuyat Ku , David Paul Kelsen , Vivian E. Strong , Heiko Schöder , Yelena Yuriy Janjigian , Manish A. Shah , Daniel G. Coit , Murray F. Brennan , Marinela Capanu , David H. Ilson

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2013 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal (Noncolorectal) Cancer

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Esophageal or Gastric Cancer

Clinical Trial Registration Number

NCT00737438

Citation

J Clin Oncol 31, 2013 (suppl; abstr 4101)

DOI

10.1200/jco.2013.31.15_suppl.4101

Abstract #

4101

Poster Bd #

23G

Abstract Disclosures

Similar Posters

First Author: Elizabeth Won

First Author: Sebastian Ochenduszko

First Author: Bettina Gabriele Muller

Poster

2015 Gastrointestinal Cancers Symposium

Novel chemotherapy combinations for metastatic gastric adenocarcinoma (mAGC): An updated meta-analysis.

Novel chemotherapy combinations for metastatic gastric adenocarcinoma (mAGC): An updated meta-analysis.

First Author: Anna Dorothea Wagner